ASCLETIS-B (01672) spent 2.4837 million Hong Kong dollars to repurchase 200,000 shares on December 23rd.
Sing Lee Pharmaceuticals Group Limited (01672) announced on December 23, 2025 the repurchase of 200,000 shares at a cost of HK$2.4837 million.
ASCLETIS-B (01672) announced that it will spend HKD 2.4837 million to repurchase 200,000 shares on December 23, 2025.
Related Articles
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
